No Picture
Los Angeles Biotech News

BAYLX, INC. Receives US FDA Clearance of COVID-19 IND Application For Umbilical Cord Tissue Mesenchymal Stem Cells Product

IRVINE, Calif.–(BUSINESS WIRE)–Baylx, Inc. (Baylx), a clinical-stage stem cell biopharmaceutical company focused on developing living stem cell products to address unmet medical needs, announced that the U.S. Food and Drug Administration (FDA) has cl… […]

No Picture
Los Angeles Biotech News

Axiom Presenting “Data Driven Studies: Unified eClinical Platforms to Run Your Clinical Trials” at Outsourcing in Clinical Trials USA Virtual Experience

IRVINE, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is a presenting sponsor and exhibitor at the Outsourcing in Clinical Trials USA Virtual Experience even… […]

No Picture
Los Angeles Biotech News

City of Hope Distinguished Scientist Debbie Thurmond Named New Director of Diabetes & Metabolism Research Institute

DUARTE, Calif.–(BUSINESS WIRE)– #CityofHope–Debbie C. Thurmond, Ph.D., has been named the new director of City of Hope’s Diabetes & Metabolism Research Institute. […]

No Picture
Los Angeles Biotech News

Pfizer infuses $200M into CStone, scoring a second PD-L1 and outlining a sprawling China pact

Pfizer has engineered a wide-ranging China pact with CStone, with an initial $200 million investment and a license to the late-stage PD-L1 drug to get things started.
The US giant now claims 9.90% of CStone’s shares on the Hong Kong stock exchange, rig… […]

No Picture
Los Angeles Biotech News

Arcutis Announces Positive Topline Data from Phase 2 Clinical Trial Evaluating ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Seborrheic Dermatitis

WESTLAKE VILLAGE, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological d… […]

No Picture
Los Angeles Biotech News

First African American Woman to Dive to the Ocean Floor and Titanic Discoverer to Headline Honorees at AltaSea’s Drive-In Experience, The Blue Hour, on October 10

LOS ANGELES–(BUSINESS WIRE)–AltaSea at the Port of Los Angeles will honor two ocean exploration pioneers, Dr. Dawn Wright and Dr. Robert Ballard, during their inaugural The Blue Hour, a spectacular drive-in experience focusing on LA as the global cap… […]

No Picture
Los Angeles Biotech News

Biocom Appoints Stephanie Hsieh as Executive Director of its Los Angeles Office

SAN DIEGO & LOS ANGELES–(BUSINESS WIRE)– #California–Biocom, the association representing the life science industry of California, today announced the appointment of Stephanie Hsieh as the organization’s executive director for its Los Angeles of… […]

No Picture
Los Angeles Biotech News

Lyre’s Non-Alcoholic Spirits Secures $11.5 Million in Seed Funding

LOS ANGELES–(BUSINESS WIRE)–Lyre’s Non-Alcoholic Spirit Co., the world’s most awarded line of non-alcoholic spirits and a key player in the emerging segment, has secured a total of $11.5 million (USD) in growth capital at the close of seed round fund… […]

No Picture
Los Angeles Biotech News

Silverback dishes out two promotions in C-suite; Legend CEO post changes hands again

Valerie Odegard
→ Accompanying the news that they just scored an $85 million Series C round, Laura Shawver-led Silverback Therapeutics has promoted two execs, with Valerie Odegard adding president to her CSO duties and Naomi Hunder moving to CMO. A Nov… […]